Cardinal Health, Inc. $CAH Shares Acquired by JSF Financial LLC

JSF Financial LLC increased its holdings in Cardinal Health, Inc. (NYSE:CAH) by 4.4% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 9,448 shares of the company’s stock after acquiring an additional 397 shares during the period. JSF Financial LLC’s holdings in Cardinal Health were worth $1,587,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in CAH. MassMutual Private Wealth & Trust FSB lifted its stake in shares of Cardinal Health by 3.6% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,767 shares of the company’s stock valued at $297,000 after purchasing an additional 62 shares during the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management raised its holdings in Cardinal Health by 0.4% in the 2nd quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 17,805 shares of the company’s stock valued at $2,991,000 after buying an additional 69 shares during the period. Perigon Wealth Management LLC raised its holdings in Cardinal Health by 3.2% in the 2nd quarter. Perigon Wealth Management LLC now owns 2,314 shares of the company’s stock valued at $389,000 after buying an additional 72 shares during the period. Community Bank & Trust Waco Texas increased its position in shares of Cardinal Health by 1.3% during the second quarter. Community Bank & Trust Waco Texas now owns 5,598 shares of the company’s stock valued at $940,000 after acquiring an additional 74 shares during the last quarter. Finally, Pinnacle Bancorp Inc. increased its position in shares of Cardinal Health by 11.2% during the first quarter. Pinnacle Bancorp Inc. now owns 767 shares of the company’s stock valued at $106,000 after acquiring an additional 77 shares during the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

CAH has been the subject of a number of research analyst reports. Citigroup reaffirmed a “neutral” rating and set a $170.00 price objective (up previously from $157.00) on shares of Cardinal Health in a research report on Friday, June 13th. Weiss Ratings reiterated a “buy (b)” rating on shares of Cardinal Health in a report on Saturday, September 27th. Leerink Partners decreased their price objective on Cardinal Health from $188.00 to $186.00 and set an “outperform” rating for the company in a research note on Tuesday, August 12th. Robert W. Baird lifted their price objective on Cardinal Health from $197.00 to $203.00 and gave the company an “outperform” rating in a research note on Wednesday, August 13th. Finally, Jefferies Financial Group set a $150.00 target price on shares of Cardinal Health in a report on Tuesday, August 12th. Twelve equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and an average target price of $165.93.

Insider Transactions at Cardinal Health

In other news, insider Michelle D. Greene sold 13,500 shares of Cardinal Health stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the sale, the insider owned 14,976 shares in the company, valued at approximately $2,228,728.32. The trade was a 47.41% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Jason M. Hollar sold 35,901 shares of the firm’s stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $150.04, for a total value of $5,386,586.04. Following the transaction, the chief executive officer owned 200,000 shares in the company, valued at $30,008,000. This represents a 15.22% decrease in their position. The disclosure for this sale can be found here. Insiders sold 271,676 shares of company stock valued at $40,489,525 over the last quarter. 0.12% of the stock is owned by corporate insiders.

Cardinal Health Stock Performance

Shares of NYSE CAH opened at $154.50 on Friday. Cardinal Health, Inc. has a fifty-two week low of $106.98 and a fifty-two week high of $168.44. The firm has a market capitalization of $36.71 billion, a PE ratio of 23.95, a price-to-earnings-growth ratio of 1.31 and a beta of 0.71. The stock’s 50-day simple moving average is $152.07 and its 200-day simple moving average is $150.38.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, beating the consensus estimate of $2.03 by $0.05. The company had revenue of $60.16 billion for the quarter, compared to analyst estimates of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm’s revenue was up .5% on a year-over-year basis. During the same period in the prior year, the firm posted $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, sell-side analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be given a $0.5107 dividend. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.3%. Cardinal Health’s payout ratio is 31.63%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.